Encapsulation of mono- and oligo-nucleotides into aqueous-core nanocapsules in presence of various water-soluble polymers

被引:44
作者
Hillaireau, H.
Le Doan, T.
Chacun, H.
Janin, J.
Couvreur, P.
机构
[1] Univ Paris Sud, UMR 8612, CNRS, F-92296 Chatenay Malabry, France
[2] CNRS, UMR 8612, F-92296 Chatenay Malabry, France
[3] CNRS, UPR 9063, F-91198 Gif Sur Yvette, France
关键词
poly(alkylcyanoacrylate); nanocapsules; azidothymidine-triphosphate; cidofovir; oligonucleotides;
D O I
10.1016/j.ijpharm.2006.10.031
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In a previous study, we have shown that cidofovir (CDV) and azidothymidine-triphosphate (AZT-TP) were poorly encapsulated in poly(isobutylcyanoacrylate) (PIBCA) aqueous-core nanocapsules. This was attributed to the rapid leakage of these small and hydrophilic molecules through the thin polymer wall of the nanocapsules. In the present study, we have selected various water-soluble polymers as increasing Mw adjuvants and investigated their influence on the entrapment of mononucleotides (CDV, AZT-TP) as well as of oligonucleotides (ODN) into these PIBCA aqueous-core nanocapsules. We show here that the presence of cationic polymers (i.e. poly(ethyleneimine) (PEI) or chitosan) in the nanocapsule aqueous compartment allowed successful encapsulation of AZT-TP and ODN. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:148 / 152
页数:5
相关论文
共 15 条
[1]   Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: Influences of surface morphology, length, and type of polysaccharide [J].
Bertholon, Isabelle ;
Vauthier, Christine ;
Labarre, Denis .
PHARMACEUTICAL RESEARCH, 2006, 23 (06) :1313-1323
[2]   ADSORPTION OF OLIGONUCLEOTIDES ONTO POLYISOHEXYLCYANOACRYLATE NANOPARTICLES PROTECTS THEM AGAINST NUCLEASES AND INCREASES THEIR CELLULAR UPTAKE [J].
CHAVANY, C ;
SAISONBEHMOARAS, T ;
LEDOAN, T ;
PUISIEUX, F ;
COUVREUR, P ;
HELENE, C .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1370-1378
[3]   POLYALKYLCYANOACRYLATE NANOPARTICLES AS POLYMERIC CARRIERS FOR ANTISENSE OLIGONUCLEOTIDES [J].
CHAVANY, C ;
LEDOAN, T ;
COUVREUR, P ;
PUISIEUX, F ;
HELENE, C .
PHARMACEUTICAL RESEARCH, 1992, 9 (04) :441-449
[4]   Encapsulation of antiviral nucleotide analogues azidothymidine-triphosphate and cidofovir in poly(iso-butylcyanoacrylate) nanocapsules [J].
Hillaireau, H. ;
Le Doan, T. ;
Besnard, M. ;
Chacun, H. ;
Janin, J. ;
Couvreur, P. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 324 (01) :37-42
[5]   Design of anti-HIV compounds: from nucleoside to nucleoside 5′-triphosphate analogs. Problems and perspectives [J].
Kukhanova, M ;
Krayevsky, A ;
Prusoff, W ;
Cheng, YC .
CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (05) :585-598
[6]   Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides [J].
Lambert, G ;
Fattal, E ;
Pinto-Alphandary, H ;
Gulik, A ;
Couvreur, P .
PHARMACEUTICAL RESEARCH, 2000, 17 (06) :707-714
[7]   EWS Fli-1 antisense nanocapsules inhibits Ewing sarcoma-related tumor in mice [J].
Lambert, G ;
Bertrand, JR ;
Fattal, E ;
Subra, F ;
Pinto-Alphandary, H ;
Malvy, C ;
Auclair, C ;
Couvreur, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (02) :401-406
[8]   Transport, metabolism and elimination mechanisms of anti-HIV agents [J].
Li, XL ;
Chan, WK .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 39 (1-3) :81-103
[9]   Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats [J].
Lobenberg, R ;
Araujo, L ;
von Briesen, H ;
Rodgers, E ;
Kreuter, J .
JOURNAL OF CONTROLLED RELEASE, 1998, 50 (1-3) :21-30
[10]   Macrophage targeting of azidothymidine: A promising strategy for AIDS therapy [J].
Lobenberg, R ;
Kreuter, J .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (18) :1709-1715